Revolver Therapeutics
Develops peptide therapeutics targeting transcription factors for cancer treatment
Highlights
- Young companyFounded 2023
- New on EvolcAdded 2026-11-10
About Revolver Therapeutics
Revolver Therapeutics develops peptide therapeutics designed to target transcription factors. Its proprietary screening platform identifies functional inhibitors by screening peptides.
The company is based in Bath, United Kingdom, and was founded in 2023. Its team includes scientists and specialists in platform technology and peptide optimisation.
Product: Peptide therapeutics and a discovery platform for identifying inhibitors that target transcription factors.
Jobs at Revolver Therapeutics
Leadership
- Mark Treherene · CEOSource: company website
- Jody Mason · Founder & CSOSource: company website
More biotech & pharma companies
Richmond Pharmacology
Early-phase clinical trial CRO in London running first-in-human and gene-editing studies for pharma and biotech sponsorsNew on EvolcRemote-friendlyRinri Therapeutics
Develops regenerative cell therapies for people with sensorineural hearing lossNew on EvolcRivopharm (UK)
Supplies generic and branded medicines to UK wholesalers, pharmacies and hospitalsNew on EvolcRna Agribio
RNA-based biopesticides in development to protect UK oilseed rape crops from insect pestsYoung companyNew on EvolcRoukenBio
Preclinical immunology contract research for biotech drug developers, from discovery to pre-IND testingRX Farma
Generic medicines manufacturer and supplier selling prescription and OTC products to UK wholesalers and pharmacy groupsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WixHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Monitoring
- SentryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
